Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single vs Double Dose Iron for Anemia Prevention in Obese Pregnant Women
NCT04101461Completed
- Sponsor
- Assiut University
- Start
- Oct 2019
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of PharaFerro in iron deficiency anemia (IDA) (2 arms), sponsored by Assiut University. Primary endpoint: The number of anemic women at time of delivery. Started Oct 2019; status: completed.
02
Drugs
PharaFerro
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT04101461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04101461.